Katharina Jeromin

Six-month real-world outcomes from the UP-RISING study: Patient beliefs in medicines and use of digital health applications in German patients with RA

Johannes Knitza, Patrizia Sternad, Daniel Bestler, Nicolai Steinchen et autres

Introduction: Upadacitinib (UPA) and TNF inhibitors (TNFi) are established therapies for patients with rheumatoid arthritis (RA) [ref:1], [ref:2], [ref:3], [ref:4], [ref:5], [ref:6], while digital health applications (DiGA) are relatively new [for full text, please go to the a.m. URL]

de (code pays fourni par la source)

Effectiveness and Safety of Upadacitinib in Treating Oligoarticular and Polyarticular Psoriatic Arthritis: Primary Analysis from the UPJOINT-Study

S. G. Werner, Ilka Schwarze, Xenofon Baraliakos, Michael Fiene et autres

This study aimed to investigate the effectiveness and safety of upadacitinib in patients with either oligo- or polyarticular active psoriatic arthritis (oPsA/pPsA) in routine clinical practice. UPJOINT is a post-marketing, multicenter observational study in patients with active psoriatic arthritis (PsA), treated with …

de, ee, ca, fr (code pays fourni par la source)

POS0967 REAL-WORLD USE OF UPADACITINIB AND IMPACT ON MINIMAL DISEASE ACTIVITY IN PATIENTS WITH OLIGO- OR POLY-ARTICULAR PSORIATIC ARTHRITIS: DATA FROM THE UPJOINT STUDY

S. G. Werner, Ilka Schwarze, X. Baraliakos, Michael Fiene et autres

Predictors for severe persisting pain in rheumatoid arthritis are associated with pain origin and appraisal of pain

Christoph Baerwald, Edgar Stemmler, Sixten Gnüchtel, Katharina Jeromin et autres

OBJECTIVES: To determine the proportion of patients with rheumatoid arthritis (RA) with severe persisting pain and to identify predictive factors despite treatment-controlled disease activity. METHODS: This prospective multicentre study included outpatients with RA scheduled for escalation of anti-inflammatory treatment due to active …

de, gb (code pays fourni par la source)

Treatment with Upadacitinib in Active Psoriatic Arthritis: Efficacy and Safety Data of the First 192 Patients from the UPJOINT Study, a Multicentre, Observational Study in Clinical Practice

S. G. Werner, Xenofon Baraliakos, Sabine Reckert, M. Bohl-Bühler et autres

Our aim was to investigate the efficacy and safety of upadacitinib (UPA) in patients with either oligo- or polyarticular active psoriatic arthritis (PsA) using routine clinical practice data from an observational, prospective, multicentre study. This interim analysis contains upadacitinib efficacy and safety …

de, ca (code pays fourni par la source)

POS0598 PERSISTING PAIN IN RHEUMATOID ARTHRITIS: DO WE NEED TO RECONSIDER OUR IDEA OF PAIN ALLEVIATION DESPITE ANTI-INFLAMMATORY TREATMENT?

C. Baerwald, E. Stemmler, S. Gnuechtel, Katharina Jeromin et autres

de, gb (code pays fourni par la source)